Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Lactoferrin for Inflammation in HIV
NCT01830595Phase 2Completed
- Start
- Sep 2014
- Primary completion
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of lactoferrin in human immunodeficiency virus infection (HIV). Started Sep 2014; status: completed.
02
Drugs
lactoferrin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01830595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830595.